Biotech stocks: Not for the faint of heart
The sector has outperformed the rest of the TASE this year by a wide margin, but the stocks are subject to intense volatility.
Israeli biotechnology stocks have been experiencing a comeback this year, with the Tel Aviv Stock Exchange’s TA-Biomed index advancing 25%, easily outpacing the 15% gain by the blue-chip TA-25 index.
register with haaretz
Like us on Facebook and get articles directly in your news feed